找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of Breast Diseases; Ismail Jatoi,Achim Rody Book 2016Latest edition Springer International Publishing Switzerland 2016 Breast I

[復(fù)制鏈接]
樓主: 自治
31#
發(fā)表于 2025-3-27 00:08:40 | 只看該作者
32#
發(fā)表于 2025-3-27 02:49:14 | 只看該作者
33#
發(fā)表于 2025-3-27 08:28:39 | 只看該作者
Surgical Considerations in the Management of Primary Invasive Breast Cancer,tomy (CPM), and breast-conserving surgery (BCS). Following BCS, radiation therapy (RT) is often required to reduce the risk of ipsilateral breast tumor recurrence, although older patients with indolent tumors may not require radiotherapy after BCS. Moreover, radiotherapy is required for selected hig
34#
發(fā)表于 2025-3-27 09:26:46 | 只看該作者
Management of the Axilla,nd accepted as standard of care worldwide. Dual localization methods with blue dye and radioisotope are associated with optimal performance parameters such as shorter learning curve, higher identification rates and low false-negative rates. Several issues relating to surgical technique and choice of
35#
發(fā)表于 2025-3-27 16:31:24 | 只看該作者
Breast Reconstructive Surgery,mmetrical breast mound after mastectomy. Breast reconstruction can be at the time of mastectomy or as a delayed procedure. Options for reconstruction include prosthetic implants, autologous tissue, or both. Implant reconstruction is a relatively simple and effective method of breast reconstruction,
36#
發(fā)表于 2025-3-27 20:43:08 | 只看該作者
The Role of Radiotherapy in Breast Cancer Management, recurrent carcinoma of the breast. Despite the technical limitations of the early equipment, tumor shrinkage and at times complete elimination of the tumor were noticed. However, the full potential of radiation therapy could not be achieved in those early days because of the limited knowledge regar
37#
發(fā)表于 2025-3-28 01:04:14 | 只看該作者
38#
發(fā)表于 2025-3-28 04:39:19 | 只看該作者
Endocrine Therapy,ausal women, tamoxifen is the standard in low-risk patients, providing a significant reduction in both risk of recurrence and BC mortality; the addition of ovarian function suppression (OFS) to tamoxifen or the aromatase inhibitor (AI) Exemestane is recommended in patients at higher risk of relapse.
39#
發(fā)表于 2025-3-28 07:04:14 | 只看該作者
40#
發(fā)表于 2025-3-28 13:46:58 | 只看該作者
http://image.papertrans.cn/m/image/622451.jpg
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
黄大仙区| 荆州市| 杭锦旗| 千阳县| 陈巴尔虎旗| 垫江县| 桦甸市| 濮阳县| 泰顺县| 永清县| 九龙城区| 洛宁县| 深水埗区| 沧源| 河曲县| 溧水县| 云和县| 招远市| 四平市| 托克逊县| 武川县| 四平市| 都兰县| 定襄县| 灵台县| 开阳县| 汉寿县| 桂东县| 安泽县| 汝城县| 昌吉市| 郴州市| 台湾省| 德化县| 克拉玛依市| 安岳县| 慈溪市| 广东省| 荃湾区| 太原市| 广东省|